1DI MAIO M, DE MAIO E, PERRONE F,et al. Hepatocellular carcinoma: systemic treatments [J]. J Clin Gastroenterol, 2002,35(5 Suppl 2): S 109- 114.
2HASHIDA M, NISHIKAWA M,YAMASHITA F, et al. Cell-specific delivery of genes with glycosyated carriers[J] . Adv Drug Deliv Rev, 2001, 52(3):187 - 196.
3YAMASAKI Y, SUMIMOTO K,NLISHIKAWA M, et al. Pharmacokinetic analysis of in vivo scavenger receptors importance of molecular size and negative charge density for in vivo recognition by receptors [J] . J Pharmacol Exp Ther,2002, 301 (2): 467 - 477.
4OPANASOPIT P, HIGUCHI Y,KAWAKAMI S, et al. Involvement of mannan binding proteins and receptors in uptake off mannosylated liposomes by macrophages[J] . Biocbip Biopsy's Acta, 2001, 1511(1): 134- 145.
5OPANASOPIT P, SHIRASHI K,NISHIKAWA M, et al. In vivo recognition of annosylated protenins by hepatic mannose receptors and mannan-binding protein [J].Am J Physiol Gastrointcst Liver Physiol,2001, 280(5): G879 - 889.
6KAWAKAMI S, SATO A, NISHIKAWA M, et al. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes [J]. Gene Ther, 2000, 7(4): 292 - 299.
7KAWAKAMI S, YAMASHITA F,NISHIDA K, et al. Glyeosylated cationnic liposomes for cell-selective gene delivery[ J] . Crit Rev Ther Drug Carrier Syst,2002, 19 (2): 171 - 190.
8OPANASOPIT P, SAKAI M, NISHIKAWAM, et al. Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers [J] . J Control Release, 2002, 80(1-3): 283-294.
9KAWAKAMI S, MUNAKATA C, FUMOTO S, et al. Novel galactosylated liposomes for hepatocyte-selective targeting of lipophillc drugs [J] . J Pharm Sci, 2001, 90(2):105 - 113.
10CATFEL L, CEBUTI M, DOSIO F, From conventional to stealth liposomes: a newforontier in cancer chemotherapy [J] .Tumori, 2003, 89(3): 237 - 249.
